Lifecore Biomedical, Inc. (LFCR)
收市後：
| 前收市價 | 6.57 |
| 開市 | 6.55 |
| 買盤 | 6.26 x 500 |
| 賣出價 | 6.32 x 300 |
| 今日波幅 | 6.28 - 6.65 |
| 52 週波幅 | 4.13 - 11.46 |
| 成交量 | |
| 平均成交量 | 195,148 |
| 市值 | 191.835M |
| Beta 值 (5 年，每月) | 0.98 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -2.14 |
| 業績公佈日 | 2024年5月13日 - 2024年5月16日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 8.00 |
Insider MonkeyHidden Gems: Unveiling the 10 Stocks on Hedge Funds’ Radar
In this article we are going to reveal the names of 10 stocks that are on hedge funds’ radar. The US market sustained strong performance in the first quarter of 2024 as the S&P Index increased by 10.6%, continuing its momentum from the previous quarter. There is a prevailing optimism in the market regarding a […]
Insider MonkeyWhat Made White Falcon Hold Lifecore Biomedical (LFCR)?
White Falcon Capital Management, an investment fund manager, released its first quarter 2024 investor letter. A copy of the same can be downloaded here. The portfolio achieved a satisfactory result on an absolute basis during the quarter. In the first quarter, the fund was up 8.7% compared to a 12.8% return for the S&P 500 […]
Insider MonkeyDo You Believe in the Upside Trajectory of Lifecore Biomedical (LFCR)?
Investment management company Cove Street Capital recently released its “Small Cap Value Fund” first quarter 2024 investor letter. A copy of the same can be downloaded here. In the first quarter, the fund returned 1.61% compared to 5.18% for the Russell 2000 Index and 2.90% for the Russell 2000 Value Index. The first quarter of calendar year 2024 […]
